-
Innoviva NASDAQ:INVA Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.
Location: 2000 Sierra Point Pkwy Ste 500, California, 94005-1830, US | Website: www.inva.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.52B
Cash
260.6M
Avg Qtr Burn
N/A
Short % of Float
23.35%
Insider Ownership
1.07%
Institutional Own.
-
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
XACDURO Details Acinetobacter infection | Approved Quarterly sales | |
Xerava (eravacycline) Details Intra-abdominal infections | Approved Quarterly sales | |
Giapreza (angiotensin II) Details Septic shock | Approved Quarterly sales |